Cargando…
Improving Osteosarcoma Treatment: Comparative Oncology in Action
Osteosarcoma (OSA) is the most common pediatric malignant bone tumor. Although surgery together with neoadjuvant/adjuvant chemotherapy has improved survival for localized OSA, most patients develop recurrent/metastatic disease with a dismally poor outcome. Therapeutic options have not improved for t...
Autores principales: | Tarone, Lidia, Mareschi, Katia, Tirtei, Elisa, Giacobino, Davide, Camerino, Mariateresa, Buracco, Paolo, Morello, Emanuela, Cavallo, Federica, Riccardo, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783386/ https://www.ncbi.nlm.nih.gov/pubmed/36556464 http://dx.doi.org/10.3390/life12122099 |
Ejemplares similares
-
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
por: Tarone, Lidia, et al.
Publicado: (2022) -
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)
por: Camerino, Mariateresa, et al.
Publicado: (2021) -
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
por: Riccardo, Federica, et al.
Publicado: (2019) -
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
por: Riccardo, Federica, et al.
Publicado: (2022) -
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases
por: Giacobino, Davide, et al.
Publicado: (2021)